BiotechTube
Home/LiberoThera/Yoichi Okumura
YO

Yoichi Okumura

President & CEO

LiberoThera

Therapeutic Areas

OncologyImmunology

LiberoThera Pipeline

DrugIndicationPhase
Anti-CCR8 antibodyCancer (likely solid tumors)Preclinical

Leadership Team at LiberoThera

TK
Toru Kanke, Ph.D.
Director
MO
Makoto Ohori, Ph.D.
Director
SA
Sakae Asanuma, CFA, MBA
Director
SO
Shota Ozawa, Ph.D.
Director
View full LiberoThera profile